Drug application
TRAVASOL 3.5% SULFITE FREE W/ ELECTROLYTES IN PLASTIC CONTAINER (AMINO ACIDS, MAGNESIUM CHLORIDE, POTASSIUM PHOSPHATE, DIBASIC and 2 more)
Drugs@FDA NDA 020177 · BAXTER HLTHCARE
Key facts
| Drug name | TRAVASOL 3.5% SULFITE FREE W/ ELECTROLYTES IN PLASTIC CONTAINER |
|---|---|
| Active ingredients | AMINO ACIDS, MAGNESIUM CHLORIDE, POTASSIUM PHOSPHATE, DIBASIC, SODIUM ACETATE, SODIUM CHLORIDE |
| Application type | NDA |
| Application number | 020177 |
| Company | BAXTER HLTHCARE |
| Dosage forms | INJECTABLE, INJECTION |
| Strength | 3.5%;51MG/100ML;131MG/100ML;218MG/100ML;35MG/100ML |
| Marketing status | Discontinued |
| Reference listed drug | No |
| Latest submission class | Type 5 - New Formulation or New Manufacturer |
| Latest submission status date | Oct 23, 1995 |
At a glance
- 1–9 Submissions
- 10–99 Supplements
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.